WHO ICTRP trial

Does intravenous iron administration in pregnancy change blood vessel and heart…

ACTRN12616000173493 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12616000173493
Public title Does intravenous iron administration in pregnancy change blood vessel and heart function?
Scientific title Effects of the correction of iron deficiency by iron infusion on cardiovascular function in pregnancy – a pilot study
Primary sponsor Lyell McEwin Hospital
Secondary sponsors University of Adelaide
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries Australia
Conditions iron deficiency in pregnancy;iron deficiency anaemia in pregnancy; iron deficiency in pregnancy iron deficiency anaemia in pregnancy;Cardiovascular - Normal development and function of the cardiovascular system;Blood - Anaemia;Reproductive…
Interventions Healthy pregnant women undergoing ferric carboxymaltose (FCM) infusion as per obstetric team. In women > 50kg the current standard approach is a single 1000mg FCM infusion. We will measure cardiac and vascular function in a non-invasive…
Registration date Nov 2, 2016
Target size 15
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations